RLAY
RLAY
NASDAQ · Biotechnology

Relay Therapeutics Inc

$9.56
-0.26 (-2.65%)
As of Mar 24, 2:01 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +582.3% upside
Low Target $47.67
Average Target $65.23
High Target $99.61
Current Price $9.56
Current
$9.56
Target
$65.23
$47.67 $65.23 avg $99.61
Scenario Analysis
Bear Case
$47.67
398.6%
Low target
Base Case
$65.23
+582.3%
Avg target
Bull Case
$99.61
+941.9%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$9.54
0.2% from high
52-Week Low
$1.78
+438.6% from low
Target vs 52W High
$65.23
+583.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%